Oddo BHF Asset Management Sas Has $16.55 Million Stock Position in Danaher Corporation $DHR

Oddo BHF Asset Management Sas lifted its stake in Danaher Corporation (NYSE:DHR) by 92.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 72,285 shares of the conglomerate’s stock after purchasing an additional 34,817 shares during the quarter. Oddo BHF Asset Management Sas’ holdings in Danaher were worth $16,547,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Elevated Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter valued at $26,000. Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher during the 4th quarter valued at about $27,000. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the last quarter. JPL Wealth Management LLC bought a new position in shares of Danaher in the 3rd quarter valued at approximately $25,000. Finally, WFA of San Diego LLC bought a new position in shares of Danaher in the 2nd quarter valued at approximately $26,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

DHR opened at $181.04 on Tuesday. The stock has a market cap of $128.13 billion, a PE ratio of 35.02, a P/E/G ratio of 2.30 and a beta of 0.81. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock’s 50 day simple moving average is $180.73 and its 200-day simple moving average is $204.27.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.88 earnings per share. Sell-side analysts forecast that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s payout ratio is currently 30.95%.

Analyst Upgrades and Downgrades

DHR has been the topic of several recent analyst reports. Argus dropped their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Evercore lifted their price target on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 21st. Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Finally, Rothschild & Co Redburn set a $205.00 price objective on Danaher in a research report on Friday, April 17th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $233.61.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.